Find Contract (CMO / CDMO) Services of Drug Product Manufacturing for Tablet

One Pharma has expertise in the development and manufacturing of sustained and oral-controlled release tablets. It also offers sugar-coated and slow-release tablets with an annual production capacity of 800 million per shift.

Category : Tablet

Sub Category : Sustained Release

Pharma Service : Drug Product Manufacturing

02

LGM Pharma

U.S.A

BMWS24

Not Confirmed

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Pharma Service : Drug Product Manufacturing

LGM Pharma has a complete set of technologies and capabilities to expertly manufacture oral solid dosage forms including sustained, immediate, controlled, and extended release, coated, uncoated, and orally dissolving tablets (ODTs).

Category : Tablet

Sub Category : Sustained Release

Pharma Service : Drug Product Manufacturing

03

Renejix

U.S.A

BMWS24

Not Confirmed

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Pharma Service : Drug Product Manufacturing

Renejix leverages its expertise in the development and manufacturing of sustained, controlled, immediate, modified, delayed, and pulsatile release tablets and capsules along with mini-tablets and ODTs.

Category : Tablet

Sub Category : Sustained Release

Pharma Service : Drug Product Manufacturing

04

Ethypharm

France

CPhI WW Frankfurt

Booth #5.0D100

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Pharma Service : Drug Product Manufacturing

Ethypharm is a CDMO specializing in the contract manufacturing of sustained-release, highly potent mono & bi-layer tablets. Its expertise in Flashtab, Nanosizing, Multicaps, Transmucosal, & ODT technologies enables it to develop innovative formulations.

Category : Tablet

Sub Category : Sustained Release

Pharma Service : Drug Product Manufacturing

For more than 45 years Mikart has been involved in the contract manufacturing of sustained, controlled, modified, delayed, and extended-release tablets. It also produces mini, multi-layered, chewable, fast dissolve (ODT), taste-masked, and coated tablets.

05

Mikart

U.S.A

BMWS24

Not Confirmed

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Pharma Service : Drug Product Manufacturing

CMO FOR SUSTAINED RELEASE TABLETS

Category : Tablet

Sub Category : Sustained Release

Pharma Service : Drug Product Manufacturing